Brief: Xbrane Biopharma Q4 EBITDA Loss Widens To SEK 18.0 Mln

Xbrane Biopharma AB

28/02/2018 07:07

Feb 28 (Reuters) - XBRANE BIOPHARMA AB  XBRANE.ST : 
    * Q4 EBITDA LOSS SEK 18.0 MILLION VERSUS LOSS SEK 8.1 
MILLION 
YEAR AGO 
    * PROPOSE NO DIVIDEND FOR FISCAL YEAR 2017 
 
Source text for Eikon:  ID:nGNE77jKq3  
Further company coverage:  XBRANE.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))